Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes

E-ISSN： 1097-0045|75|5|463-473

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.5, 2015-04, pp. : 463-473

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic variations in MyD88 adaptor-like are associated with atopic dermatitis

International Journal of Molecular Medicine, Vol. 27, Iss. 6, 2011-01 ,pp. : 795-801

Spandidos Publications

Access to resources Recommend Favorite

Requirement of MyD88 and Fas pathways for the efficacy of allergen‐free immunotherapy

ALLERGY, Vol. 70, Iss. 3, 2015-03 ,pp. : 275-284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dendritic cell specific targeting of MyD88 signalling pathways in vivo

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 1, 2015-01 ,pp. : 32-39

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of NY-ESO-1 in Triple-Negative Breast Cancer Is Associated with Tumor-Infiltrating Lymphocytes and a Good Prognosis

Oncology, Vol. 89, Iss. 6, 2015-09 ,pp. : 337-344

Karger

Access to resources Recommend Favorite

Citrobacter rodentium Infection Induces MyD88-Dependent Formation of Ubiquitinated Protein Aggregates in the Intestinal Epithelium

Journal of Innate Immunity, Vol. 3, Iss. 1, 2010-10 ,pp. : 83-98

Karger

Access to resources Recommend Favorite